Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong · Delayed Price · Currency is HKD 61.30
-1.90 (-3.01%)
Sep 10, 2026, 11:59 AM HKT
Nanjing Leads Biolabs Market Cap
Nanjing Leads Biolabs has a market cap or net worth of 12.33 billion as of September 9, 2026. Its market cap has decreased by -5.41% in one year.
Market Cap
12.33B
Enterprise Value
11.33B
Revenue
246.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
61.30
ChartMarket Cap Chart
Since July 25, 2025, Nanjing Leads Biolabs's market cap has decreased from 12.97B to 12.33B, a decrease of -4.96%. That is a compound annual growth rate of -4.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 12.33B | 21.57% |
| Dec 31, 2025 | 10.14B | -21.82% |
| Jul 25, 2025 | 12.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Duality Biotherapeutics | 16.28B |
| HBM Holdings | 12.56B |
| Ascentage Pharma Group International | 12.35B |
| Everest Medicines | 11.00B |
| Ascletis Pharma | 10.66B |
| GenFleet Therapeutics (Shanghai) | 10.33B |
| Suzhou Ribo Life Science | 9.70B |
| CStone Pharmaceuticals | 9.68B |